Latin America
CHOP, Brazilian National Cancer Institute to Bring Automated Cell Therapy Manufacturing to Brazil
The institutions will use a $4 million grant to launch a Rio de Janeiro-based center equipped with an automated closed-system CAR T-cell therapy platform.
Myriad Genetics, GSK Collaborate on International Ovarian Cancer Testing Program
GSK will provide financial support for a program to expand access to Myriad's MyChoice tests for patients with high-grade serous ovarian cancer.
Caring Cross developed a method of manufacturing CAR T-cell therapies for about one-tenth of the typical cost and partnered with Fiocruz to deploy it in Brazil.
OmnigenicsAI, MultiplAI Health to Merge, Go Public in $340M SPAC Deal
The transaction, which is expected to close midyear, will result in OmnigenicsAI becoming publicly traded on the Nasdaq under the ticker symbol OMNI.
Thermo Fisher Scientific, Pfizer Partner to Bring NGS-Based Cancer Tests to Underserved Markets
The collaboration will expand NGS-based tests for lung and breast cancers in more than 30 countries, where advanced genomic testing has been limited.